Research on rTMS and Alzheimer’s Disease

Recent studies indicate that low-intensity repetitive transcranial magnetic stimulation (rTMS) might help restore important synaptic structures in mouse models of Alzheimer’s disease. Researchers discovered that axonal boutons—where neurons connect—exhibited decreased turnover in mice with Alzheimer’s, suggesting a loss of brain plasticity.

After just one rTMS session, the turnover of a specific type of bouton notably increased, reaching levels comparable to healthy mice. These findings imply that rTMS could partially address synaptic deficits and improve brain connectivity.

Key Insights

• Boost in Synaptic Turnover: rTMS led to a turnover increase of up to 213% in AD mice.
• Targeted Response: Only terminaux boutons showed change after rTMS, leaving en passant boutons unaffected.
• Therapeutic Implications: rTMS appeared to nearly restore impaired synaptic plasticity.

Alzheimer’s disease (AD) poses a major challenge globally among the elderly. This neurodegenerative condition severely impacts cognitive functions, profoundly affecting quality of life.

Synapses, crucial for communication between neurons, can adapt based on experiences—strengthening or weakening as needed. Disruption in this adaptability is a significant feature of AD, complicating memory and cognitive abilities. Presently, there’s no definitive cure, and treatment options are mostly limited to symptom management.

rTMS, a non-invasive technique using electromagnetic pulses to stimulate specific brain areas, is recognized for its potential in alleviating dementia symptoms. While there is evidence showing rTMS can enhance synaptic plasticity in healthy systems, its effects on dementia are less understood and often varied among patients.

A collaborative study from the University of Queensland and the Wicking Dementia Research and Education Centre examined how rTMS impacts synapses in the cortex of Alzheimer’s-type dementia mice. In their publication in Neurophotonics, lead researcher Dr. Barbora Fulopova elaborated on how they measured changes in axonal boutons in response to rTMS, comparing results from AD mice to healthy counterparts.

Axonal boutons are critical for neuronal communication, allowing signals to bridge gaps between neurons. Alterations in these boutons can significantly influence brain connectivity. The researchers focused on two excitatory bouton types: “terminaux boutons” (TBs), which connect local neurons, and “en passant boutons” (EPBs), which link more distant regions. They utilized advanced imaging techniques to observe individual axons and synapses in live mice.

The study involved a specialized mouse strain, which glows under certain conditions due to a fluorescent protein. This feature allowed for precise monitoring of bouton changes over time, comparing data from these mice with healthy ones at intervals.

Initially, both bouton types in AD mice displayed a similar density to those in healthy mice, but the turnover rates were significantly lower in the AD group, likely due to amyloid plaque accumulation—an indicator of dementia-related diseases.

Post-stimulation, TB turnover showed a remarkable increase, while EPB turnover remained unchanged. The most notable uptick was recorded two days following stimulation, with increases of 88% for healthy mice and a striking 213% for the AD mice. However, this heightened turnover reverted to baseline by day eight.

This suggests that low-intensity rTMS may enhance synaptic plasticity in TBs in AD mice, bringing them closer to levels seen in healthy subjects. Interestingly, the selective response of only TBs hints at potential cell-type specific mechanisms linked to rTMS.

Dr. Fulopova highlighted this as a pioneering study showing rTMS’s effect on pre-synaptic boutons in both healthy and dementia-affected brains. Given the known relationship between synaptic dysfunction and cognitive decline in dementia, and the traditional use of rTMS for other neurodegenerative disorders, these results underscore rTMS’s potential in enhancing existing Alzheimer’s management strategies.

This research represents an important advancement in the quest to understand Alzheimer’s disease, signaling a hopeful path towards more targeted rTMS therapies that might ultimately improve life quality for those affected.